HIV and Neurological complications in Thailand
|
|
|
- Sophie Lamb
- 9 years ago
- Views:
Transcription
1 HIV and Neurological complications in Thailand Khuanchai Supparatpinyo Division of Infectious Disease Department of Medicine Chiang Mai University, Thailand
2 Agenda Epidemiology of HIV in Thailand Epidemiology of HIV opportunistic infections in Thailand Antiretroviral therapy in Thailand Epidemiology of HIV neurological complications in Thailand
3
4 Epidemiology of HIV in Thailand First AIDS patient: 1984 First epidemic wave ( ): Homosexual men Second epidemic wave ( ): IVDU Third epidemic wave ( ): Female prostitutes and clients Fourth epidemic wave (1991-now): Spouse and mother-to-child
5 HIV seroprevalence in Thailand ( ) HIV Positive (%) IDU DFP IFP STD ANC Blood Donor Year Source: Division of Epidemiology, Thai Ministry of Public Health
6 Estimated number of new HIV infections in Thailand by year and changing mode of transmission Source: Thai Working Group on HIV/AIDS Projections, 2001
7 HIV epidemic in Thailand 140,000 new cases/year (1991) to 21,000 new cases/year (2002) Mode of transmission: SW 90% (1990) to spouse 50%, IVDU 20%, SW 15% (2002) HIV prevention is ineffective in IVDU, homosexual men
8 HIV/AIDS Situation in Thailand (Sep Apr 2005) Number Deaths Reported cases 359,704 86,443 AIDS 268,706 75,263 Symptomatic 90,998 11,180 Source: Division of AIDS, TB, and STD, Thai Ministry of Public Health
9 Number of AIDS patients/deaths in Thailand Number AIDS Deaths Year Source: Division of Epidemiology, Thai Ministry of Public Health
10 AIDS patients in Thailand (Sep 1984-Apr 2005) Percentage y 5-9 y y y 20-24y 25-29y 30-34y 35-39y 40-44y 45-49y 50-54y 55-59y 60+y Age group Source: Division of Epidemiology, Thai Ministry of Public Health
11 Mode of transmission of HIV in Thailand (%) Heterosexual Unknown IVDU MTCT Blood Tx Others Source: Division of Epidemiology, Thai Ministry of Public Health
12 AIDS cases according to region in Thailand, Chariyalertsak, et al. CID 2001;32:
13 Agenda Epidemiology of HIV in Thailand Epidemiology of HIV opportunistic infections in Thailand Antiretroviral therapy in Thailand Epidemiology of HIV neurological complications in Thailand
14 Opportunistic Infections (Sep 1984 to Apr 2005) Rank Opportunistic Infection Number % 1 Tuberculosis PCP Cryptococcosis Invasive candidiasis Recurrent pneumonia Cerebral toxoplasmosis Penicilliosis marneffei AIDS dementia complex MAC Chronic herpes simplex infection Total = 268,706 AIDS patients
15 Common opportunistic infections according to region in Thailand, Chariyalertsak, et al. CID 2001;32:
16 Agenda Epidemiology of HIV in Thailand Epidemiology of HIV opportunistic infections in Thailand Antiretroviral therapy in Thailand Epidemiology of HIV neurological complications in Thailand
17 Antiretroviral therapy coverage for adults, end 2003 Source: UNAIDS/WHO, 2004
18 Antiretroviral therapy in Thailand At least AIDS patients require ART Free-of-charge antiretroviral program in Thailand , zidovudine monotherapy , dual nucleoside therapy (ZDV+ddI/ddC) , a pilot phase of triple regimen using original ARVs
19 Antiretroviral therapy in Thailand In 2002, 2500 AIDS patients (1.25%) were treated with HAART ARV price reduction in 2003: Original drugs $300+/month GPO-Vir (d4t/3tc/nvp) $30/month >5 times increase in number of patients receiving ART (>15000 cases or 7.5% in 2003)
20 Antiretroviral therapy in Thailand National policy: provide free ART (GPO- Vir ) to a total of cases in 2004 (25% coverage) Until March hospitals Total patients enrolled patients currently receiving ART
21 Agenda Epidemiology of HIV in Thailand Epidemiology of HIV opportunistic infections in Thailand Antiretroviral therapy in Thailand Epidemiology of HIV neurological complications in Thailand
22 Neurological complications in AIDS patients A retrospective study at CMU Hospital from Sep 2001 to Aug 2002 Review of 155 AIDS patients 118 male and 37 female mean age 34.5±5.4 years, range years 1.9% receiving antiretroviral drugs K. Subsai et al. Eur J Neurol 2004;11:755-9.
23 Neurological complications in AIDS patients Review of 155 AIDS patients 76 (49.0%) admitted with non-neurological S/S 35 (22.6%) admitted with neurological S/S 44 (28.4%) admitted with both neurological and non-neurological S/S Incidence of neurological complications = 50.3 per 100 person-years CNS = 46.5 per 100 person-years PNS = 3.8 per 100 person-years K. Subsai et al. Eur J Neurol 2004;11:755-9.
24 Neurological complications in AIDS patients Incidence (/100 person-years) Cryptococcal meningitis 18.0 Cerebral toxoplasmosis 14.8 CMV infection 7.0 Tuberculous meningitis 1.9 Seizure disorder 1.9 PML 1.2 Nocardial brain abscess 0.6 Peripheral neuropathy 3.8 K. Subsai et al. Eur J Neurol 2004;11:755-9.
25 Decrease in incidence (Poisson regression analysis: P<0.0001)
26 Increase in incidence (Poisson regression analysis: P<0.0001)
27 Cryptococcosis in Thailand High incidence in all regions of the country Third most common presenting OI in AIDS patients (prevalence 10-25%) Most common neurological complication Decreasing in incidence in recent years Primary prophylaxis with fluconazole Primary prophylaxis with itraconazole (northern) Access to ART
28 Cryptococcosis at CMU Hospital Number of patients ZDV monotherapy 2NRTIs HAART Fluconazole 355 1º Prophylaxis Itraconazole 1º Prophylaxis Year Data from the Central Mycology Lab, CMU Hospital
29 Summary High incidence of neurological complications in AIDS patients in Thailand Opportunistic infections are leading causes of neurological complications Cryptococcal meningitis is most common, followed by cerebral toxoplasmosis A trend of decreasing incidence of opportunistic infections in HAART era
30 Thank you for your attention
Global Update on HIV Treatment 2013: Results, Impact and Opportunities
June 2013 Global Update on HIV Treatment 2013: Results, Impact and Opportunities WHO/UNAIDS/UNICEF v2 Outline Results: Progress towards Global Targets - Antiretroviral treatment - Prevention of mother-to-child
Pediatric HIV - The World At It's Best
VIH/SIDA en Pediatría: Epidemiología Mundial, Transmisión Perinatal, Manejo Integral. Juan Carlos Salazar, M.D. Universidad de Connecticut, EE.UU. End-1998 global estimates Children (
HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer
HIV/AIDS Care: The Diagnosis Code Series 2 Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer Learning Outcomes Identify and explain the difference between ICD-9-CM
Long Term Socio-Economic Impact of HIV/AIDS on Children and Policy Response in Thailand
Long Term Socio-Economic Impact of HIV/AIDS on Children and Policy Response in Thailand Wattana S. Janjaroen Faculty of Economics and College of Public Health Chulalongkorn University Suwanee Khamman and
HIV/AIDS Prevention and Care
HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global Health Sciences and AIDS Research Institute: University
HIV infection in injecting drug users
HIV Clinical Skills Series 4 th International Training Course Tallinn 2010 HIV infection in injecting drug users Marika Raukas West-Tallinn Central Hospital Estonia InjectionDrug Users Transmission via
Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session.
Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* ABOUT THIS ACTIVITY Time: 60 minutes Objectives: By the end of this session, participants will be able to: Reviewed their knowledge of HIV/AIDS
HIV/AIDS. HIV- Human Immunodeficiency Virus. AIDS immume system severely damaged
HIV/AIDS HIV- Human Immunodeficiency Virus Person is infected with virus. May have no s/s (but may transmit virus) More common to have brief flu-like illness 2-6 wks after becoming infected (swollen lymph
Peripheral Neuropathy (painful feet)
Peripheral Neuropathy (painful feet) What does it feel like? Peripheral neuropathy is a long lasting pain that usually occurs in the lower legs. Often it is a burning sensation of the foot soles, sometimes
ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES
ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES AIDS Law Unit Legal Assistance Centre July, 2002 INTRODUCTION Although there is currently no cure for HIV/Aids, treatment has, however, been developed
Routine HIV Monitoring
Routine HIV Monitoring Guideline of the HIV/AIDS Division at San Francisco General Hospital Statement of Guideline: Patients will be routinely evaluated and monitored for HIV parameters, antiretroviral
Antiretroviral therapy for HIV infection in infants and children: Towards universal access
Antiretroviral therapy for HIV infection in infants and children: Towards universal access Executive summary of recommendations Preliminary version for program planning 2010 Executive summary Tremendous
HBV screening and management in HIV-infected children and adolescents
HBV screening and management in HIV-infected children and adolescents Linda Aurpibul M.D. Research Institute for Health Sciences, Chiang Mai University 8% HIV and Hepatitis B Co-infection Among Perinatally
GARPR Online Reporting Tool
GARPR Online Reporting Tool 0 Narrative Report and Cover Sheet 1) Which institutions/entities were responsible for filling out the indicator forms? a) NAC or equivalent Yes b) NAP Yes c) Others Yes If
The Basics of Drug Resistance:
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) [email protected] The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?
HIV/AIDS policy. Introduction
HIV/AIDS policy Introduction The International Federation of Red Cross and Red Crescent Societies (International Federation) has a long tradition of working in the area of health and care. National Red
XVIIth International Aids Conference, Mexico City
XVIIth International Aids Conference, Mexico City 5 August 2008 Parliamentary Briefing on HIV/AIDS: parliamentarians as partners in the fight against HIV. Prof. Dr. Marleen Temmerman, Senator, Belgian
Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB
Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB Dr. Christian Manzardo Hospital Clínic/IDIBAPS- Universidad de Barcelona
Tuberculosis in Myanmar Progress, Plans and Challenges
Tuberculosis in Myanmar Progress, Plans and Challenges Myanmar is one of the world s 22 high tuberculosis (TB) burden countries, with a TB prevalence rate three times higher than the global average and
Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection
Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection The Centers for Disease Control (CDC) has developed a classification system for human immunodeficiency virus (HIV) infection
What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection
Module 1 Overview of HIV Infection Purpose Pre-requisite Modules Learning Objectives To provide you with the basic terms and concepts related to HIV infection. None At the end of this module, you will
Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation. M Dinaker. Fig.1: Effect of CART on CD4 and viral load
Combination Anti-Retroviral Therapy (CART) - Rationale and Recommendation M Dinaker INTRODUCTION The wide availability of effective, safe and mostly well tolerated combined anti-retroviral therapy (CART)
Outpatient/Ambulatory Health Services
Outpatient/Ambulatory Health Services Service Definition Outpatient/ambulatory medical care includes the provision of professional diagnostic and therapeutic services rendered by a physician, physician
HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK
HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf
HIV Continuum of Care Monitoring Framework 2014
HIV Continuum of Care Monitoring Framework 2014 Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean HIV Continuum of Care Monitoring Framework
KENYA, COUNTY HIV SERVICE DELIVERY PROFILES
MINISTRY OF HEALTH KENYA, COUNTY HIV SERVICE DELIVERY PROFILES NATIONAL AIDS AND STI CONTROL PROGRAM NASCOP Table of Contents Page Content 4 Abbreviations 5 Introductions 6 Reporting rates 8 Kiambu County
CIBMTR Infection Data and the New Infection Inserts.
CIBMTR Infection Data and the New Infection Inserts. Marcie Tomblyn, MD, MS Scientific Director, CIBMTR Infection and Immune Reconstitution Working Committee Overview Indication for expanded data collection
CURRICULUM VITAE PERSONAL INFORMATION. Scott S. Ubillos, M.D.
CURRICULUM VITAE PERSONAL INFORMATION Name: Scott S. Ubillos, M.D. Office Infectious Disease Associates of Tampa Bay Address: 4 Columbia Drive, Suite 820 Tampa, FL 33606 4729 N. Habana Ave Tampa, Florida
In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.
ANTIRETROVIRAL TREATMENT What is ART and ARV? ART is a short form for Antiretroviral Therapy (or Treatment). Antiretroviral therapy is a treatment consisting of a combination of drugs which work against
The Stigma of HIV and AIDS. A Brief History of HIV/AIDS. A Brief History of HIV/AIDS. Opportunistic Infections and Modes of Transmission
Nurse Caring Concepts 1A The Stigma of HIV and AIDS Opportunistic Infections and Modes of Transmission Week 17 12-8 -03 1926-1945 HIV may have spread from monkeys to humans (may have first jumped from
Placing Nation on the Path Toward the Elimination of Hepatitis C
Placing Nation on the Path Toward the Elimination of Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for
A HISTORY OF THE HIV/AIDS EPIDEMIC WITH EMPHASIS ON AFRICA *
UN/POP/MORT/2003/2 5 September 2003 ENGLISH ONLY WORKSHOP ON HIV/AIDS AND ADULT MORTALITY IN DEVELOPING COUNTRIES Population Division Department of Economic and Social Affairs United Nations Secretariat
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report 2008. Sweden
UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS Country Progress Report 2008 Sweden ABBREVIATIONS...3 ACKNOWLEDGEMENTS...4 STATUS AT A GLANCE...1 NATIONAL INDICATOR DATA... 2 OVERVIEW OF THE
HIV Surveillance Update
HIV Surveillance Update Presentation to: CAPUS Metro Atlanta Testing and Linking Consortium (MATLC) Presented by: Deepali Rane, MPH and Jane Kelly, MD Georgia Department of Public Health Epidemiology Date:
CONNECTICUT DEPARTMENT OF PUBLIC HEALTH HEALTH CARE AND SUPPORT SERVICES HIV MEDICATION ADHERENCE PROGRAM PROTOCOL
CONNECTICUT DEPARTMENT OF PUBLIC HEALTH HEALTH CARE AND SUPPORT SERVICES HIV MEDICATION ADHERENCE PROGRAM PROTOCOL Revised July 2013 HIV MEDICATION ADHERENCE PROGRAM PROGRAM OVERVIEW People living with
Aim of Presentation. The Role of the Nurse in HIV Care. Global Epidemic 7/24/09
Aim of Presentation The Role of the Nurse in HIV Care Eileen Nixon HIV Nurse Consultant Brighton and Sussex University Hospitals Overview of key issues that affect people with HIV Identify the role of
Q&A on methodology on HIV estimates
Q&A on methodology on HIV estimates 09 Understanding the latest estimates of the 2008 Report on the global AIDS epidemic Part one: The data 1. What data do UNAIDS and WHO base their HIV prevalence estimates
AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines
AIDS Can Be Treated A Hand Book of Antiretroviral medicines The translation of this booklet is due to support from the Working Together Regional Training Project of the AIDS Access Foundation, Bangkok
Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges
Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges John B. Kaneene, DVM, MPH, PhD University Distinguished Professor of Epidemiology Director, Center for Comparative Epidemiology
UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE
UNAIDS 214 LESOTHO HIV EPIDEMIC PROFILE 214 LESOTHO Overview The Kingdom of Lesotho is landlocked and surrounded by South Africa. It has a surface area of 3 355 square kilometres and its population is
Case Finding for Hepatitis B and Hepatitis C
Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS INFORMATION NOTE Introduction The Global Fund supports evidence-based interventions that aim to ensure access to HIV prevention, treatment, care and support for
The Value of Innovation in HIV/AIDS Therapy
White Paper September 2014 The Value of Innovation in HIV/AIDS Therapy Erin Ellwanger, Harrison Kim, and Thomas Goss, PharmD Boston Healthcare Associates, Inc. Boston; Washington, D.C.; Berlin; Shangai;
Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections
Chapter 36 Media Directory Drugs for Viral Infections Slide 23 Slide 27 Slide 29 Zidovudine Animation Saquinavir Mesylate Animation Acyclovir Animation Upper Saddle River, New Jersey 07458 All rights reserved.
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item 12.3 24 May 2014. Hepatitis
SIXTY-SEVENTH WORLD HEALTH ASSEMBLY WHA67.6 Agenda item 12.3 24 May 2014 Hepatitis The Sixty-seventh World Health Assembly, Having considered the report on hepatitis; 1 Reaffirming resolution WHA63.18,
Estimates of New HIV Infections in the United States
Estimates of New HIV Infections in the United States Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new HIV infections has historically
The HIV/AIDS Epidemic in California s Latino Population
The HIV/AIDS Epidemic in California s Latino Population Barbara Bailey, M.S. Acting Chief Office of AIDS California Department of Health Services www.dhs.ca.gov/aids AIDS Incidence (Cases per 100,000)
HIV/AIDS in Southern Africa:
HIV/AIDS in Southern Africa: Background, Projections, Impacts, and Interventions Prepared by: The POLICY Project for Bureau for Africa Office of Sustainable Development US Agency for International Development
Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform
Australian Federation of AIDS Organisations (AFAO) Primary Health Care Reform 27 February 2009 1 Introduction The Australian Federation of AIDS Organisations (AFAO) is the peak body for Australia s community
HIV-related opportunistic diseases
HIV-related opportunistic diseases UNAIDS Technical update UNAIDS Best Practice Collection At a Glance Opportunistic diseases in a person with HIV are the products of two things: the person s lack of immune
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND
EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis
Audit Report. Audit of Global Fund Grants to the Republic of Ghana. GF-OIG-15-018 27 October 2015 Geneva, Switzerland
Audit Report Audit of Global Fund Grants to the Republic of Ghana GF-OIG-15-018 Geneva, Switzerland Table of Contents I. Background... 3 II. Audit Objectives, Scope and Rating... 5 III. Executive Summary...
Methodology Understanding the HIV estimates
UNAIDS July 2014 Methodology Understanding the HIV estimates Produced by the Strategic Information and Monitoring Division Notes on UNAIDS methodology Unless otherwise stated, findings in this report are
Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
Earlier, safer and simpler antiretroviral therapy can push the HIV epidemic into irreversible decline. -WHO Director-General Dr.
1616 Fort Myer Drive, 12th Floor Arlington, Virginia 22209-3100 USA www.scms.pfscm.org Telephone: +1.571.227.8600 Fax: +1.571.227.8601 SCMS Supply Lines August 2013 Content: Feature Article Trends News
HPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
The Epidemiology of Hepatitis A, B, and C
The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago [email protected] Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations
TABLE OF CONTENTS I. INTRODUCTION.. 1. Objectives and Scope..3 BACKGROUND INFORMATION ON MOTHER-TO-CHILD TRANSMISSION OF HIV 4
ii TABLE OF CONTENTS i. PREFACE.vi ii. ACKNOWLEDGMENTS. vii iii. ABBREVIATIONS.viii I. INTRODUCTION.. 1 Objectives and Scope..3 II. III. BACKGROUND INFORMATION ON MOTHER-TO-CHILD TRANSMISSION OF HIV 4
Basic Presentation HIV/AIDS. For Use by Students, Teachers and the Public Seeking Basic Information About HIV/AIDS
Basic Presentation HIV/AIDS For Use by Students, Teachers and the Public Seeking Basic Information About HIV/AIDS Objectives- Define and understand the difference between HIV Infection and AIDS Describe
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care
Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington
HIV/AIDS AND OTHER SEXUALLY TRANSMITTED INFECTIONS 11
HIV/AIDS AND OTHER SEXUALLY TRANSMITTED INFECTIONS 11 11.1 INTRODUCTION D. Zanera and I. Miteka The 2004 Malawi Demographic and Health Survey (MDHS) collected information on HIV/AIDS as well as other sexually
Fact Sheets on HIV/AIDS for nurses and midwives
Fact Sheets on HIV/AIDS for nurses and midwives Fact Sheet 1: HIV/AIDS: the infection Fact Sheet 2: The global HIV/AIDS epidemic Fact Sheet 3: Continuum of care Fact Sheet 4: Nursing care of adults with
FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.
HIV & AIDS What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease. What does HIV stand for? Human Immunodeficiency Virus Where did HIV
Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).
HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services
Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public
NATIONAL MONITORING AND EVALUATION PLAN OF THE NATIONAL STRATEGIC PLAN 2006 2011
2008 NATIONAL MONITORING AND EVALUATION PLAN OF THE NATIONAL STRATEGIC PLAN 2006 2011 Acknowledgements The National AIDS Commission would like to acknowledge the sponsorship of USAID/ PASCA in the development
UNAIDS ISSUES BRIEF 2011 A NEW INVESTMENT FRAMEWORK FOR THE GLOBAL HIV RESPONSE
UNAIDS ISSUES BRIEF 2011 A NEW INVESTMENT FRAMEWORK FOR THE GLOBAL HIV RESPONSE Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved The designations employed and the
EVALUATION OF THE BAHAMAS HIV/AIDS PROGRAMME FINAL REPORT
EVALUATION OF THE BAHAMAS HIV/AIDS PROGRAMME FINAL REPORT Submitted by: Health Economics Unit The University of the West Indies St. Augustine Republic of Trinidad and Tobago Submitted to: CARICOM Secretariat
COMMUNICABLE DISEASE
Public Health Activities & Services Inventory Technical Notes COMMUNICABLE DISEASE CLINICAL SERVICES, SURVEILLANCE AND CONTROL In 2014, decision was made to adopt number of national public health activities
HIV and AIDS in Bangladesh
HIV and AIDS in Bangladesh BACKGROUND The first case of HIV/AIDS in Bangladesh was detected in 1989. Since then 1495 cases of HIV/AIDS have been reported (as of December 2008). However UNAIDS estimates
FACULTY OF HEALTH SCIENCES DEPARTMENT OF COMMUNITY MEDICINE
FACULTY OF HEALTH SCIENCES DEPARTMENT OF COMMUNITY MEDICINE Rajesh Shigdel HEL-3950 Master s Thesis in public Health September, 2012 Supervisor: Luai A. Ahmed University of Tromsø ii H E L - 3 9 5 0 M
How To Teach People To Live With Hiv
MONITORING AND EVALUATION TOOLKIT HIV/AIDS, TUBERCULOSIS AND MALARIA Annexes: Selected Indicators for HIV/AIDS, Tuberculosis and Malaria Second Edition January 2006 Annexes: selected Indicators for HIV/AIDS,
Research priorities in medical mycology
Research priorities in medical mycology David W. Denning National Aspergillosis Centre University Hospital of South Manchester The University of Manchester Agenda How many patients are there with serious
Solid Organ Transplantation
Solid Organ Transplantation Infection Prevention And Control Transplant Atlantic 2011 October 13/2011 Kathy Hart Introduction In the past several years, the drugs that we use, the surgeries themselves,
Or download the manual from www.crhcs.org.tz or www.fantaproject.org.
is a publication of the East, Central and Southern African Health Community Secretariat (ECSA-HC), the Food and Nutrition Technical Assistance (FANTA) Project of FHI 360, and the LINKAGES Project of FHI
NICHD s Pediatric, Adolescent, & Maternal AIDS Branch
Friends of NICHD Webinar: NICHD s Pediatric, Adolescent, & Maternal AIDS Branch Lynne Mofenson, MD Branch Chief December 19, 2008 Please call in-dial: 888-517-2197 Code:7080363 Webinar Guidelines All participants
Pharmacy and Supply Chain Assessment Report
The MTCT Plus Initiative Program Start-up Assessment Report Moi Teaching and Referral Hospital/Mosoriot Rural Health Center Eldoret, KENYA January 19 22, 2003 Pharmacy and Supply Chain Assessment Report
